Gerald I Shulman MD PhD, MACP, MACE, FRCP

Grant Support

• Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetesYALE UNIVERSITY2024–2028
• Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetesYALE UNIVERSITY2024–2028
• Yale Center for Metabolic Phenotyping in Live Models of Obesity and DiabetesYALE UNIVERSITY2023–2028
• Yale Diabetes Research CenterYALE UNIVERSITY1997–2028
• Yale Diabetes Research CenterYALE UNIVERSITY1997–2028
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Mechanism of Renal Cortical Insulin ResistanceYALE UNIVERSITY2022–2026
• Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human PrimatesYALE UNIVERSITY2019–2025
• In vivo Pathway Discovery in Autosomal Dominant Polycystic Kidney DiseaseYALE UNIVERSITY2019–2025
• Mechanisms Of Lipid-Induced Hepatic Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2012
• Cellular Mechanisms Of Insulin Resistance In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2012
• Genetic And Cellular Mechanisms Of Nafld And Hepatic Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
• Mechanisms Of Fat Induced Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
• Yale Mouse Metabolic Phenotyping CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2011
• Role Of Mitochondrial Dysfunction In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
• Mitochrondrial Dysfunction: Role In Metabolic SyndromeNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
• Mechanisms Of Fatty Acid Induced Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
• Liver Lipid And Carbohydrate Metabolism In Famial HypertriglyceridemiaNational Center For Research Resources2005
• Differences Between Insulin Resistant And Non-Insulin Resistant IndividualsNational Center For Research Resources2005
• Regulation Of UCP-3 Activity And Expression In MuscleNational Center For Research Resources2004–2005
• Regulation Of Pathways Of Glycogen Repletion In Non, Pre, And Diabetic HumansNational Center For Research Resources2004
• Regulation Of Brain Metabolite Synthesis By Ketones InNational Center For Research Resources2004
• NMR Measurements Of Liver And Muscle Triglyceride Content In N/Ir StatesNational Center For Research Resources2004
• Metabolic And Physiologic Differences Between Insulin Resistant And Non-InsulinNational Center For Research Resources2004
• Metabolic And Endocrine Defects In Lean, Non-Diabetic Offspring Of NIDDM ParenNational Center For Research Resources2004
• Fatty Liver /Hepatic Insulin Resistance From High Fat FENational Center For Research Resources2004
• Effects Of FXR Activation On Hepatic Lipid And Carbohydrate MetabolismNational Center For Research Resources2004
• In Vivo NMR Studies Of Carbohydrate MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1989–2002
• NMR Of Triglyceride Content Inmuscle In Insulin ResistanNational Center For Research Resources2000–2001
• Metabolism/Physiology In Insulin&Noninsulin ResistantNational Center For Research Resources2000–2001
• Epinephrine On Hepatic Glycogenolysis &GluconeogenesisNational Center For Research Resources2000–2001
• Aspirin In Insulin Stimulated Carbohydrate MetabolismNational Center For Research Resources2000–2001
• Quantitaion Of NET Hepatic Glycogenolysis And Gluconeogenesis With MetforminNational Center For Research Resources1998–2001
• Hepatic Glucose Metabolism In IDDM (Type I) And NIDDM (Type Ii)National Center For Research Resources1998–2001
• Cortical Glutamate, Glutamine &Gaba Levels In Hepatic EncephalopathyNational Center For Research Resources1998–2001
• Mechanisms Of Insulin Resistance In Older PersonsNational Institute On Aging1997–2001
• Metabolic And Endocrine Deficits In Lean Nondiabetic Offspring Of IDDM PatientsNational Center For Research Resources1997–2001
• Mechanism Of Troglitazone Action In Type II Diabetes MellitusNational Center For Research Resources1997–2001
• Regulation Of Pathways Of Glycogen Repletion In Prediabetics And DiabeticsNational Center For Research Resources1996–2001
• Quantitation Of Hepatic Glycogenolysis And Gluconeogenesis During FastingNational Center For Research Resources1996–2001
• Effects Of Fatty Acids On Muscle Glycogen SynthesisNational Center For Research Resources1996–2001
• MRS Assessment Of Muscle Glycogen Utilization During Prolonged ExerciseNational Center For Research Resources1998–2000
• Assessment Of Intracellular Free Glucose Consentration In Insulin ResistanceNational Center For Research Resources1998–2000
• Effects Of Oral Fructose On Hepatic Glycogen Synthesis During Glucose IngestionNational Center For Research Resources1998–1999
• Effects Of Glycogen Supercompensationon Insulin Sensitivity &Muscle GlycogenNational Center For Research Resources1998–1999
• Effects Of Dietary Fat On Insulin Stimulated Muscle Glycogen SynthesisNational Center For Research Resources1998–1999
• SIX Month, Double Blind Placebo Controlled, Multicenter Trial Of TroglitazonesNational Center For Research Resources1997–1999
• NMR Studies Of Muscle Glycogen In Resting Subjects After Carbohydrate LoadingNational Center For Research Resources1997–1999
• Human Amylin Analogue Ac137 VS Placebo On Hepatic Glucogen MetabolismNational Center For Research Resources1997–1999
• Hepatic Gluconeogenesis In Normal, NIDDM, And Cirrhosis PatientsNational Center For Research Resources1996–1999
• Epinephrine Effects On Muscle Glycogenolysis And Glycogen MetabolismNational Center For Research Resources1996–1999
• Carbohydrate Metabolism In Supercompensated Muscle Using NMRNational Center For Research Resources1996–1999
• NMR Studies Of Glycogen Metabolism In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
• Pharmacokinetics Of Bay27-9955National Center For Research Resources1998
• Phase II Double Blind Placebo Controlled Multicenter Study Of TroglitazonesNational Center For Research Resources1996–1997
• NMR Measurement Of Triglyceride In Insulin Resitant/Normal MuscleNational Center For Research Resources1996–1997
• Human Amylin Analogue Ac137 VS Placebo On Hepatic Glucogen SynthesisNational Center For Research Resources1996–1997
• Functional Imaging Of Ventromedial Hypothalmus In Normal, Diabetic,And Obese PTSNational Center For Research Resources1996–1997
• Carbon 13 NMR Studies Of Liver And Muscle Glycogen TurnoverNational Center For Research Resources1996–1997
• Pancreatic Insulin Secretion In Lean Offspring Of Parents With NIDDMNational Center For Research Resources1996
• Intracellular Metabolism By Isotopes &Nmr SpectroscopyNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1988
• Intracellular Metabolism By Isotopes &Nmr SpectroscopyNational Institute Of Diabetes And Digestive And Kidney Diseases1986
• Intracellular Metabolism By Isotopes &Nmr SpectroscopyNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985